Tags

Type your tag names separated by a space and hit enter

Drug Use Evaluation of Beta-Blockers in Medical Wards of Nedjo General Hospital, Western Ethiopia.
Cardiovasc Ther. 2020; 2020:2509875.CT

Abstract

Introduction

Beta-blocker use evaluation is a performance method that focuses on the evaluation of beta-blocker use processes to achieve optimal patient outcomes. Several studies conducted in different hospitals revealed a high incidence of inappropriate prescription of beta-blockers among hospitalized patients. Therefore, it is important to identify inappropriate beta-blocker prescribing since they may increase the risk of hospitalizations. Despite this, there was no study conducted related to drug use evaluation of beta-blockers in Nedjo general hospital (NGH). Thus, this study was aimed at assessing the use evaluation of beta-blockers in medical wards of NGH.

Methods

A retrospective cross-sectional study was conducted at medical wards of NGH from January 1, 2016, to December 31, 2017.

Results

Out of the total of 149 medical record of patients that contains beta-blockers, 84 (56.37%) were males and about one-third (31.54%) of the patients ages were between 41 and 50 years. Propranolol was the most commonly prescribed beta-blocker (62.76%), and 94.56% of beta-blockers were prescribed with correct indication. There were about 51%, 46.31%, 64.43%, and 46.98% of beta-blockers prescribed with the correct dose, duration, frequency, and route of administration, respectively. Regarding the routes of administration, 70 (46.98%) of them were prescribed with the correct route. Most drugs interacting were propranolol with cimetidine 26 (68.42%), and the most frequent condition for which beta-blockers were prescribed was hypertension (32.89%).

Conclusion

Overall, there was an inappropriate use of beta-blockers in terms of dosage and durations. So, prescribers of NGH should strictly adhere to the national treatment guideline when prescribing medications. Additionally, drug information centers have proved useful and effective in promoting rational drug use. Hence, it should be recommended for general use.

Authors+Show Affiliations

Department of Pharmacy, Institute of Health Science, Wollega University, Nekemte, Ethiopia.Department of Pharmacy, College of Health Science, Mettu University, Mettu, Ethiopia.Department of Nursing, College of Health Science, Selale University, Fiche, Ethiopia.Department of Pharmacy, Institute of Health Science, Wollega University, Nekemte, Ethiopia.Department of Pharmacy, Institute of Health Science, Wollega University, Nekemte, Ethiopia.Department of Pharmaceutical Sciences, University of Kashmir, Hazratbal Srinagar, 190006 Jammu and Kashmir, India.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32565908

Citation

Fekadu, Ginenus, et al. "Drug Use Evaluation of Beta-Blockers in Medical Wards of Nedjo General Hospital, Western Ethiopia." Cardiovascular Therapeutics, vol. 2020, 2020, p. 2509875.
Fekadu G, Bekele F, Bekele K, et al. Drug Use Evaluation of Beta-Blockers in Medical Wards of Nedjo General Hospital, Western Ethiopia. Cardiovasc Ther. 2020;2020:2509875.
Fekadu, G., Bekele, F., Bekele, K., Hanbisa, S., Belay, G., & Maqbool, M. (2020). Drug Use Evaluation of Beta-Blockers in Medical Wards of Nedjo General Hospital, Western Ethiopia. Cardiovascular Therapeutics, 2020, 2509875. https://doi.org/10.1155/2020/2509875
Fekadu G, et al. Drug Use Evaluation of Beta-Blockers in Medical Wards of Nedjo General Hospital, Western Ethiopia. Cardiovasc Ther. 2020;2020:2509875. PubMed PMID: 32565908.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Drug Use Evaluation of Beta-Blockers in Medical Wards of Nedjo General Hospital, Western Ethiopia. AU - Fekadu,Ginenus, AU - Bekele,Firomsa, AU - Bekele,Kumera, AU - Hanbisa,Sagni, AU - Belay,Gemechis, AU - Maqbool,Mudasir, Y1 - 2020/05/22/ PY - 2020/04/01/received PY - 2020/05/12/revised PY - 2020/05/16/accepted PY - 2020/6/23/entrez PY - 2020/6/23/pubmed PY - 2020/7/21/medline SP - 2509875 EP - 2509875 JF - Cardiovascular therapeutics JO - Cardiovasc Ther VL - 2020 N2 - Introduction: Beta-blocker use evaluation is a performance method that focuses on the evaluation of beta-blocker use processes to achieve optimal patient outcomes. Several studies conducted in different hospitals revealed a high incidence of inappropriate prescription of beta-blockers among hospitalized patients. Therefore, it is important to identify inappropriate beta-blocker prescribing since they may increase the risk of hospitalizations. Despite this, there was no study conducted related to drug use evaluation of beta-blockers in Nedjo general hospital (NGH). Thus, this study was aimed at assessing the use evaluation of beta-blockers in medical wards of NGH. Methods: A retrospective cross-sectional study was conducted at medical wards of NGH from January 1, 2016, to December 31, 2017. Results: Out of the total of 149 medical record of patients that contains beta-blockers, 84 (56.37%) were males and about one-third (31.54%) of the patients ages were between 41 and 50 years. Propranolol was the most commonly prescribed beta-blocker (62.76%), and 94.56% of beta-blockers were prescribed with correct indication. There were about 51%, 46.31%, 64.43%, and 46.98% of beta-blockers prescribed with the correct dose, duration, frequency, and route of administration, respectively. Regarding the routes of administration, 70 (46.98%) of them were prescribed with the correct route. Most drugs interacting were propranolol with cimetidine 26 (68.42%), and the most frequent condition for which beta-blockers were prescribed was hypertension (32.89%). Conclusion: Overall, there was an inappropriate use of beta-blockers in terms of dosage and durations. So, prescribers of NGH should strictly adhere to the national treatment guideline when prescribing medications. Additionally, drug information centers have proved useful and effective in promoting rational drug use. Hence, it should be recommended for general use. SN - 1755-5922 UR - https://www.unboundmedicine.com/medline/citation/32565908/Drug_Use_Evaluation_of_Beta-Blockers_in_Medical_Wards_of_Nedjo_General_Hospital,_Western_Ethiopia L2 - https://doi.org/10.1155/2020/2509875 DB - PRIME DP - Unbound Medicine ER -